Get the Stockscreener App
1.76
1.12%
-0.02
After Hours:
1.76
Actinium Pharmaceuticals Inc stock is traded at $1.76, with a volume of 156.59K.
It is down -1.12% in the last 24 hours and down -1.68% over the past month.
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.
See More
Previous Close:
$1.78
Open:
$1.75
24h Volume:
156.59K
Relative Volume:
0.55
Market Cap:
$54.90M
Revenue:
$1.05M
Net Income/Loss:
$-48.82M
P/E Ratio:
-0.9617
EPS:
-1.83
Net Cash Flow:
$-47.49M
1W Performance:
+7.32%
1M Performance:
-1.68%
6M Performance:
+60.00%
1Y Performance:
-11.56%
1-Day Range:
$1.73
$1.7998
1-Week Range:
$1.62
$1.8059
52-Week Range:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Name
Actinium Pharmaceuticals Inc
Sector
Industry
Phone
646-767-3870
Address
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.76 | 55.53M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| May-14-24 | Initiated | Stephens | Overweight |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Feb-21-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-08-22 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-25-22 | Initiated | B. Riley Securities | Buy |
| Nov-05-20 | Initiated | Alliance Global Partners | Buy |
| Dec-06-17 | Initiated | B. Riley FBR, Inc. | Buy |
| Oct-23-17 | Resumed | ROTH Capital | Buy |
| Sep-14-17 | Initiated | Maxim Group | Buy |
| Aug-25-16 | Initiated | ROTH Capital | Buy |
| Feb-29-16 | Initiated | H.C. Wainwright | Buy |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Oct-01-14 | Initiated | MLV & Co | Buy |
| Jul-22-14 | Initiated | Canaccord Genuity | Buy |
View All
Actinium Pharmaceuticals Inc Stock (ATNM) Latest News
Sector ETF performance correlation with Actinium Pharmaceuticals Inc.CPI Data & AI Based Buy/Sell Signal Reports - Newser
Can Actinium Pharmaceuticals Inc. hit a new high this monthQuarterly Trade Report & Weekly Momentum Picks - Newser
Actinium Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Will Actinium Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Update & Real-Time Chart Pattern Alerts - Newser
Will Actinium Pharmaceuticals Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - Newser
How to manage a losing position in Actinium Pharmaceuticals Inc.Quarterly Portfolio Summary & Target Return Focused Picks - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
What to expect from Actinium Pharmaceuticals Inc. in the next 30 daysMarket Growth Summary & Long-Term Safe Investment Ideas - Newser
Using Bollinger Bands to evaluate Actinium Pharmaceuticals Inc.Analyst Upgrade & Stock Market Timing Techniques - Newser
What indicators show strength in Actinium Pharmaceuticals Inc.July 2025 Breakouts & Weekly High Return Opportunities - Newser
Will Actinium Pharmaceuticals Inc. see short term momentumTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Earnings visualization tools for Actinium Pharmaceuticals Inc.July 2025 EndofMonth & Intraday High Probability Alerts - Newser
Bullish Candlestick Pattern Forms in Actinium Pharmaceuticals Inc.Weekly Profit Report & Smart Allocation Stock Tips - 더경남뉴스
Visual analytics tools that track Actinium Pharmaceuticals Inc. performance2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
What institutional flow reveals about Actinium Pharmaceuticals Inc.Quarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Actinium Pharmaceuticals Inc. Chart Enters High Volatility ZoneTrade Ideas & Weekly Chart Analysis and Trade Guides - newsyoung.net
Is Actinium Pharmaceuticals Inc. meeting your algorithmic filter criteriaIPO Watch & Low Drawdown Investment Strategies - Newser
Can technical indicators confirm Actinium Pharmaceuticals Inc.’s reversalJuly 2025 Price Swings & Weekly Breakout Stock Alerts - Newser
What is Actinium Pharmaceuticals Inc.’s market positionMarket Risk Summary & High Accuracy Investment Signals - theviewers.co.kr
Is Now a Good Time to Reenter Actinium Pharmaceuticals Inc.Market Risk Report & Free Risk Controlled Daily Trade Plans - beatles.ru
Aug Movers: Can Actinium Pharmaceuticals Inc. expand its profit marginsJuly 2025 Update & Daily Chart Pattern Signal Reports - sundaytimes.kr
Actinium Pharmaceuticals Inc. Recovery Likely Here’s What Data ShowsJuly 2025 Update & Low Risk Profit Maximizing Plans - beatles.ru
Are Bears Losing Grip on Actinium Pharmaceuticals Inc.2025 Risk Factors & Weekly Breakout Opportunity Watchlist - mustnews.co.kr
Reversal Traders Monitor Actinium Pharmaceuticals Inc. for EntryMarket Risk Analysis & Risk Controlled Daily Trade Plans - mustnews.co.kr
How to track smart money flows in Actinium Pharmaceuticals Inc.2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Does Actinium Pharmaceuticals Inc. qualify in momentum factor screeningRecession Risk & Low Risk Entry Point Tips - Newser
Predicting Actinium Pharmaceuticals Inc. trend using moving averages2025 Sector Review & Short-Term High Return Strategies - Newser
Will Volume Confirm Reversal in Actinium Pharmaceuticals Inc.July 2025 Summary & Technical Confirmation Alerts - newsyoung.net
Analyzing drawdowns of Actinium Pharmaceuticals Inc. with statistical toolsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmaps2025 Top Gainers & Technical Pattern Alert System - Newser
Actinium Pharmaceuticals Inc Stock (ATNM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):